v3.26.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Three Months Ended
September 30,		Nine Months Ended
September 30,
(in thousands)2026202520262025
Cost of revenue
$6,124 $6,626 $20,751 $21,737 
Selling and marketing
9,499 15,009 42,509 45,168 
Research and development
6,010 7,914 23,972 23,789 
General and administrative
7,046 13,492 23,488 30,502 
$28,679 $43,041 $110,720 $121,196 
Income tax benefit
$(5,466)$(547)$(21,720)$(1,700)
Schedule of Stock-Based Compensation Expense Grants
Nine Months Ended
September 30, 2026
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
2,222 $97,287 
Non-qualified stock options
3,423 $58,826 
Performance stock options (2)
1,497 $25,804 
Common stock27 $875 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of Common Stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. Performance stock options granted in the nine months ended September 30, 2026 vest on the second anniversary of the grant date, up to 200%, subject to the achievement of specified performance metrics over fiscal years 2026 and 2027. The options expire ten years from the grant date.